OrbiMed Advisors LLC's Form 4 filing
Compass Therapeutics, Inc. (CMPX) · filed Nov 8, 2021
- Accession no.
- 0000947871-21-001150
- Filed
- Nov 8, 2021, 9:06 PM ET
- Trade date
- Nov 4, 2021
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market purchases total $18.8M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| OrbiMed Advisors LLCCIK 0001055951 | Director, 10% Owner |
| OrbiMed Capital GP V LLCCIK 0001615374 | Director, 10% Owner |
| OrbiMed Genesis GP LLCCIK 0001808744 | Director, 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 4, 2021 | Common Stock | PPurchaseAcquired | +1,785,715 | $3.50F1 | +$6,250,002.5 | 14,500,119 | Indirect | Duplicate filing |
| Nov 4, 2021 | Common Stock | PPurchaseAcquired | +3,571,428 | $3.50F1 | +$12,499,998 | 3,571,428 | Indirect | Duplicate filing |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
These shares of the Issuer's common stock were purchased in the Issuer's underwritten public offering.
Referenced by the price of 2 transactions in Table I.